Ajanta Pharma Limited (NSE India Code : AJANTPHARM)       SELL

Company Name :
 NSE SYMBOL :  
Enter Company Name or NSE Code

AJANTPHARM Technical Levels

Resistance 2 422.42
Resistance 1 416.53
PIVOT 413.02
Support 1 407.13
Support 2 397.73

AJANTPHARM Fundamentals

Earning Growth 17.93%
Profit Margin 10.57
PE 15.92
EPS 45.95
Quarter 30-Sep-11

AJANTPHARM Futures

Close
Contracts Traded
Open Interest(OI)
Change in OI
Lot Size

AJANTPHARM Options

Most Active Call
Most Active Put
Highest OI Call
Highest OI Put
Expiry Date

AJANTPHARM Technical Levels


Other Stocks from Pharmaceuticals Sector  AARTIDRUGS   ABBOTINDIA   AJANTPHARM   ALCHEM   ALKALI   ALPA   AMRUTANJAN   ANKURDRUGS   ARL   ASTRAZEN   AUROPHARMA   AVENTIS   BALPHARMA   BIOCON   BLISSGVS   CADILAHC   CELESTIAL   CIPLA   DISHMAN   DIVISLAB   DRREDDY   ELDERPHARM   FDC   FKONCO   GLAXO   GLENMARK   GRANULES   INDOCO   INDSWFTLAB   INDSWFTLTD   IPCALAB   JAGSNPHARM   JBCHEPHARM   JUBILANT   KILITCH   KOPRAN   LUPIN   LYKALABS   MANGALAM   MERCK   MOREPENLAB   NATCOPHARM   NECLIFE   NEULANDLAB   OPTOCIRCUI   ORCHIDCHEM   PANACEABIO   PARABDRUGS   PFIZER   PIRHEALTH 

AJANTPHARM Share Price on 5-10-2012

Open 409.95
High 410.15
Low 390.55
Close 393
Volume 22168
Change -14.9 (-3.65%)
Series EQ
Date of Listing 29-May-00
Paid Up Value 10
Face Value 10
Market Capital 0 Crores
52 Week High/Low 803.8 / 288
Get share widget

Ajanta Pharma Limited Company Profile

Ajanta Pharma (AJANTAPH) is an existing, profit making, dividend paying company engaged in manufacturing and marketing of pharmaceutical formulations worldwide, having presence in more than 52 countries. With its mission of ?Serving Global Health Care Needs Worldwide? the company has been consistently providing affordable and quality medicines to the patients across world. Established in 1973, the company has rich experience of 35 years in the industry with impeccable record of quality and timely delivery. Ajanta Pharma`s accomplishments are consistently seen with focus on product innovation through R&D in the fast growing speciality therapeutic segments of Cardiology, Ophthalmology, Dermatology,ENT & Pediatrics, Orthopedics and Nephrology which gives it an edge in international market. Financials The company announced rise of 73.96% in standalone net profit on y-o-y basis to Rs 174.66 million, while total income climbed 16.34% y-o-y basis to Rs 1.26 billion for the quarter ended March 2011.

AJANTPHARM Intraday Realtime Chart

AJANTPHARM Corporate Announcements

DATE PURPOSE
02-Aug-12 Disclosure under SEBI Takeover Regulations
01-Aug-12 Disclosure under SEBI Takeover Regulations
30-Jul-12 Minutes of Annual General Meeting
25-Jul-12 Disclosure under SEBI Takeover Regulations
19-Jul-12 Financial Result Updates

AJANTPHARM Corporate Actions

DATE PURPOSE
09-Aug-12 FV SPLIT FRM RS10 TO RS 5
09-Aug-12 Face Value Split From Rs. 10/- To Rs. 5/-
28-Jun-12 Annual General Meeting/Dividend Rs 7.50 Per Share
28-Jun-12 AGM/DIV RS 7.50 PER SHARE
23-Jun-11 Dividend-Rs.5/- Per Share

AJANTPHARM Board Meetings

MEETING DATE PURPOSE
19-Jul-12 Un-audited Financial Results
26-Apr-12 Results/Dividend/Stock-split
24-Jan-12 Un-audited Financial Results
24-Oct-11 Un-audited Financial Results
28-Jul-11 Un-audited Financial Results

AJANTPHARM Related companies

Symbol Company Name
AARTIDRUGS Aarti Drugs Limited
ABBOTINDIA Abbott India Limited
AJANTPHARM Ajanta Pharma Limited
ALCHEM Alchemist Limited
ALKALI Alkali Metals Limited

Most Active NSE INDIA Stocks

 HDFC   LITL   IVRCLINFRA   HDIL   UNITECH   JPASSOCIAT   GVKPIL   TATAMOTORS   IFCI   IBREALEST   ESSAROIL   GMRINFRA   BIRLAPOWER   HINDALCO   BHEL   RENUKA   RCOM   DLF   SUZLON   RELCAPITAL   IDFC   ADANIENT   ITC   TATAPOWER   BALLARPUR 

Free Stock Market Tips:

VJonDalalStreet Paid Tips

Home
Stock Market IPO
Mutual Funds
Education Paid Service
About us
Share Market
IPO Watch
MF News
IPO
Subscription
VJonDalalStreet
Technical Analysis
New IPO Review
Old Funds
Articles
Equity Performance
DalalStreet Blog
Stock Market News Indian IPO News
New Funds
Stock Market
Futures Performance
Free Sms Alerts
World Stock Market
IPO Allotment Status
Best Funds
Financial Terms
Options Performance
Privacy Stock Recommendations
Grey Market Premium MF Analysis Futures & Options Jackpot Performance
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither VJonDalalStreet.com website nor any of its promoters shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes acceptance of our Disclaimer
Follow VJonDalalStreet on Facebook Follow VJonDalalStreet on Twitter Follow VJonDalalStreet Blog Email VJonDalalStreet